MMCLUB

[Naztrader]

Star - CYPB..................................................

Its possible. Not to be a killjoy, but bear in mind that several phara's have had some positive news this week. It may be giving a lift to the overall sector.

From Briefing.com today:

14:58 ET MOGN MGI Pharma tgt raised to $48 from $35 at JPM Sec (41.10 -0.10). The target increase to $48 is based on improved market sentiment and reduced product risk resulting from FDA approval and commercial launch of Aloxi, co's lead product for chemotherapy induced nausea and vomiting that was approved in July.

Also the $510 million Aventis & Regeneron experimental cancer drug deal earlier this week was huge for Regeneron. Regeneron's future was looking bleak several months ago. Back on 3/31/03, the stock plunged 56% after the company released news that the Phase 3 clinical trial data for its obesity drug candidate wasn't as positive as investors had hoped.

http://biz.yahoo.com/rb/030908/health_aventis_3.html

So things are looking up this week in pharmaland. Hopefully the deal will be announced soon.

Good luck.


Regards,




Naz